BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17385207)

  • 1. Fmoc-2-mercaptobenzothiazole, for the introduction of the Fmoc moiety free of side-reactions.
    Isidro-Llobet A; Just-Baringo X; Ewenson A; Alvarez M; Albericio F
    Biopolymers; 2007; 88(5):733-7. PubMed ID: 17385207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Fmoc-beta-Ala-OH and Fmoc-beta-Ala-amino acid-OH as new impurities in Fmoc-protected amino acid derivatives.
    Hlebowicz E; Andersen AJ; Andersson L; Moss BA
    J Pept Res; 2005 Jan; 65(1):90-7. PubMed ID: 15686539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aspartimide problem in Fmoc-based SPPS. Part I.
    Mergler M; Dick F; Sax B; Weiler P; Vorherr T
    J Pept Sci; 2003 Jan; 9(1):36-46. PubMed ID: 12587881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of Fmoc-beta-alanine during Fmoc-protections with Fmoc-OSu.
    Obkircher M; Stähelin C; Dick F
    J Pept Sci; 2008 Jun; 14(6):763-6. PubMed ID: 18219706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(N-Fmoc)-3-(N-Boc-N-methoxy)-diaminopropanoic acid, an amino acid for the synthesis of mimics of O-linked glycopeptides.
    Carrasco MR; Brown RT; Doan VH; Kandel SM; Lee FC
    Biopolymers; 2006; 84(4):414-20. PubMed ID: 16508952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of in situ silylation for improved, convenient preparation of fluorenylmethoxycarbonyl (Fmoc)-protected phosphinate amino acids.
    Li S; Whitehead JK; Hammer RP
    J Org Chem; 2007 Apr; 72(8):3116-8. PubMed ID: 17375960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of N-nosyl- and N-Fmoc-N-methyl-alpha-amino acids.
    Di Gioia ML; Leggio A; Liguori A; Perri F
    J Org Chem; 2007 May; 72(10):3723-8. PubMed ID: 17439178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel N omega-xanthenyl-protecting groups for asparagine and glutamine, and applications to N alpha-9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase peptide synthesis.
    Han Y; Solé NA; Tejbrant J; Barany G
    Pept Res; 1996; 9(4):166-73. PubMed ID: 8914163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and application of Fmoc-His(3-Bum)-OH.
    Mergler M; Dick F; Sax B; Schwindling J; Vorherr TH
    J Pept Sci; 2001 Sep; 7(9):502-10. PubMed ID: 11587189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-->O-Acyl shift in Fmoc-based synthesis of phosphopeptides.
    Eberhard H; Seitz O
    Org Biomol Chem; 2008 Apr; 6(8):1349-55. PubMed ID: 18385841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient and highly selective deprotection of N-Fmoc-alpha-amino acid and lipophilic N-Fmoc-dipeptide methyl esters with aluminium trichloride and N,N-dimethylaniline.
    Di Gioia ML; Leggio A; Le Pera A; Siciliano C; Liguori A; Sindona G
    J Pept Res; 2004 Apr; 63(4):383-7. PubMed ID: 15102056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geometrical and conformational preferences of the 9-fluorenylmethoxycarbonyl-amino moiety.
    Broda MA; Mazur L; Kozioł AE; Rzeszotarska B
    J Pept Sci; 2004 Jul; 10(7):448-61. PubMed ID: 15298180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.
    Busnel O; Bi L; Dali H; Cheguillaume A; Chevance S; Bondon A; Muller S; Baudy-Floc'h M
    J Org Chem; 2005 Dec; 70(26):10701-8. PubMed ID: 16355988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A straightforward synthesis of 5'-peptide oligonucleotide conjugates using N(alpha)-Fmoc-protected amino acids.
    Ocampo SM; Albericio F; Fernández I; Vilaseca M; Eritja R
    Org Lett; 2005 Sep; 7(20):4349-52. PubMed ID: 16178530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Fmoc-polyamino acids for solid-phase synthesis of defined polyamidoamines.
    Schaffert D; Badgujar N; Wagner E
    Org Lett; 2011 Apr; 13(7):1586-9. PubMed ID: 21375314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A one-pot procedure for the preparation of N-9-fluorenylmethyloxycarbonyl-α-amino diazoketones from α-amino acids.
    Siciliano C; De Marco R; Guidi LE; Spinella M; Liguori A
    J Org Chem; 2012 Dec; 77(23):10575-82. PubMed ID: 23146162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.
    Ruczyński J; Lewandowska B; Mucha P; Rekowski P
    J Pept Sci; 2008 Mar; 14(3):335-41. PubMed ID: 17975850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise preparation of N(alpha)-Fmoc-N(epsilon)-(Boc, methyl)-lysine and its application in the synthesis of site-specifically lysine monomethylated peptide.
    Huang ZP; Du JT; Su XY; Chen YX; Zhao YF; Li YM
    Amino Acids; 2007 Jul; 33(1):85-9. PubMed ID: 17031472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,7-Di-tert-butyl-Fmoc-P-OSu: a new polymer-supported reagent for the protection of the amino group.
    Chinchilla R; Dodsworth DJ; Nájera C; Soriano JM
    Bioorg Med Chem Lett; 2002 Jul; 12(14):1817-20. PubMed ID: 12086824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.